Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 12 Aug 2022

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma

in Thoracic Oncology

Xiongfeng Chen
Lili Yu
Kun Hao
Xiaoqing Yin
Mingshu Tu
Liqing Cai
Liangming Zhang
Xiaojie Pan
Qi Gao
Yi Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.935184

3,877 views
18 citations

Review

Published on 12 Aug 2022

Choosing the optimal immunotherapeutic strategies for non-small cell lung cancer based on clinical factors

in Thoracic Oncology

Natsuki Nakagawa
Masanori Kawakami

Frontiers in Oncology

doi 10.3389/fonc.2022.952393

5,461 views
7 citations

Original Research

Published on 11 Aug 2022

A radiomics nomogram for invasiveness prediction in lung adenocarcinoma manifesting as part-solid nodules with solid components smaller than 6 mm

in Thoracic Oncology

Teng Zhang
Chengxiu Zhang
Yan Zhong
Yingli Sun
Haijie Wang
Hai Li
Guang Yang
Quan Zhu
Mei Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.900049

2,864 views
8 citations

Review

Published on 11 Aug 2022

Current treatments for non-small cell lung cancer

in Thoracic Oncology

Qianqian Guo
Liwei Liu
Zelong Chen
Yannan Fan
Yang Zhou
Ziqiao Yuan
Wenzhou Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.945102

28,902 views
116 citations

Case Report

Published on 11 Aug 2022

Personalized treatment of extensive stage small cell lung cancer: A case report and literature review

in Thoracic Oncology

Huaiyu Wang
Xuning Wang
Suxin Jiang
Jingna Zhu
Jie Liu
Chuanhong Zhou
Yanjun Zhu
Yong Han

Frontiers in Oncology

doi 10.3389/fonc.2022.956372

3,844 views
2 citations

Original Research

Published on 11 Aug 2022

Microwave ablation with local pleural anesthesia for subpleural pulmonary nodules: our experience

in Thoracic Oncology

Liangliang Meng
Bin Wu
Xiao Zhang
Xiaobo Zhang
Yingtian Wei
Xiaodong Xue
Zhongliang Zhang
Xin Zhang
Jing Li
Xiaofeng He

Frontiers in Oncology

doi 10.3389/fonc.2022.957138

4,051 views
7 citations

Original Research

Published on 10 Aug 2022

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%

in Thoracic Oncology

Ilaria Attili
Carmine Valenza
Celeste Santoro
Gabriele Antonarelli
Pamela Trillo Aliaga
Ester Del Signore
Chiara Catania
Gianluca Spitaleri
Antonio Passaro
Filippo de Marinis

Frontiers in Oncology

doi 10.3389/fonc.2022.980765

5,867 views
15 citations

Original Research

Published on 10 Aug 2022

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery

in Thoracic Oncology

Congkuan Song
Zilong Lu
Donghang Li
Shize Pan
Ning Li
Qing Geng

Frontiers in Oncology

doi 10.3389/fonc.2022.890033

3,869 views
10 citations

Original Research

Published on 10 Aug 2022

The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm

in Thoracic Oncology

Liangdong Xu
Hangcheng Zhou
Gaoxiang Wang
Zhining Huang
Ran Xiong
Xiaohui Sun
Mingsheng Wu
Tian Li
Mingran Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.954317

3,185 views
13 citations

Systematic Review

Published on 10 Aug 2022

Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients

in Thoracic Oncology

Wenchao Yang
Bixia Xuan
Mengqi Chen
Xiaofang Li
Jiana He
Haiyan Si
Yefei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.883514

3,192 views
1 citation

Original Research

Published on 10 Aug 2022

Development and validation of a deep learning model to predict survival of patients with esophageal cancer

in Thoracic Oncology

Chen Huang
Yongmei Dai
Qianshun Chen
Hongchao Chen
Yuanfeng Lin
Jingyu Wu
Xunyu Xu
Xiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.971190

6,278 views
17 citations

Case Report

Published on 09 Aug 2022

Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review

in Thoracic Oncology

Jian Wang
Xiaoyue Xiao
Xiaorong Dong
Gang Wu
Xinghua Wang
Ruiguang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.931074

3,640 views
2 citations

Case Report

Published on 09 Aug 2022

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review

in Thoracic Oncology

Tanya Zlatanova
Jeliazko Arabadjiev
Galina Kirova-Nedyalkova
Diana Nikova

Frontiers in Oncology

doi 10.3389/fonc.2022.907321

3,512 views
4 citations

Original Research

Published on 08 Aug 2022

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma

in Thoracic Oncology

Qin Hu
Runtian Wang
Huiyun Ma
Zhouwei Zhang
Qun Xue

Frontiers in Oncology

doi 10.3389/fonc.2022.922332

12,507 views
48 citations

Perspective

Published on 08 Aug 2022

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine

in Thoracic Oncology

Malinda Itchins
Nick Pavlakis

Frontiers in Oncology

doi 10.3389/fonc.2022.959637

9,799 views
3 citations

Case Report

Published on 08 Aug 2022

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

in Thoracic Oncology

Chaoyuan Liu
Min Lu
Yang Yang
Xiang Wang
Fang Ma
Xianling Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.961539

2,811 views
7 citations

Original Research

Published on 08 Aug 2022

Comparison of hook-wire and medical glue for CT-guided preoperative localization of pulmonary nodules

in Thoracic Oncology

Huijun Zhang
Ying Li
Xiaofeng Chen
Zelai He

Frontiers in Oncology

doi 10.3389/fonc.2022.922573

2,940 views
23 citations

Original Research

Published on 05 Aug 2022

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations

in Thoracic Oncology

Tiantian Ma
Jin Jiao
Ran Huo
Xiaofang Li
Guotao Fang
Qi Zhao
Weiwei Liu
Xiao Han
Chenglin Xi
Yanan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.922899

4,655 views
23 citations

Case Report

Published on 04 Aug 2022

Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health

in Thoracic Oncology

Luigi Vimercati
Domenica Cavone
Francesco Fortarezza
Maria Celeste Delfino
Romina Ficarella
Angela Gentile
Angela De Palma
Giuseppe Marulli
Luigi De Maria
Concetta Caporusso

Frontiers in Oncology

doi 10.3389/fonc.2022.966063

9,153 views
5 citations

Original Research

Published on 04 Aug 2022

Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study

in Thoracic Oncology

Yang Gao
Juan Jiang
Desheng Xiao
Yanwu Zhou
Yufan Chen
Huaping Yang
Lijing Wang
Jun Zeng
Baimei He
Ruoxi He

Frontiers in Oncology

doi 10.3389/fonc.2022.969545

5,565 views
20 citations

Original Research

Published on 03 Aug 2022

Reduction of inter-observer variability using MRI and CT fusion in delineating of primary tumor for radiotherapy in lung cancer with atelectasis

in Thoracic Oncology

Hongjiao Zhang
Chengrui Fu
Min Fan
Liyong Lu
Yiru Chen
Chengxin Liu
Hongfu Sun
Qian Zhao
Dan Han
Baosheng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.841771

3,042 views
12 citations

Original Research

Published on 03 Aug 2022

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

in Thoracic Oncology

Rachel Evans
Kelvin Lee
Paul K. Wallace
Mary Reid
Jason Muhitch
Askia Dozier
Circe Mesa
Patricia L. Luaces
Orestes Santos-Morales
Adrienne Groman

Frontiers in Oncology

doi 10.3389/fonc.2022.958043

6,579 views
10 citations

Original Research

Published on 02 Aug 2022

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

in Thoracic Oncology

Yi Dong
Yingge Li
Yi Yao
Qibin Song

Frontiers in Oncology

doi 10.3389/fonc.2022.897323

4,466 views
10 citations

Correction

Published on 02 Aug 2022

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report

in Thoracic Oncology

Zibo Zhang
Yujun Li
Yan Dong
Jia Li
Bin Zhang
Chunxia Zhang
Xiaonan Cui

Frontiers in Oncology

doi 10.3389/fonc.2022.980842

1,888 views

1,964 articles

articles

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma

Choosing the optimal immunotherapeutic strategies for non-small cell lung cancer based on clinical factors

A radiomics nomogram for invasiveness prediction in lung adenocarcinoma manifesting as part-solid nodules with solid components smaller than 6 mm

Current treatments for non-small cell lung cancer

Personalized treatment of extensive stage small cell lung cancer: A case report and literature review

Microwave ablation with local pleural anesthesia for subpleural pulmonary nodules: our experience

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery

The prognostic influence of histological subtypes of micropapillary tumors on patients with lung adenocarcinoma ≤ 2 cm

Comparison of Efficacy and Safety Between Immunotherapy and Docetaxel Monotherapy in NSCLC Patients

Development and validation of a deep learning model to predict survival of patients with esophageal cancer

Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review

Successful treatment with docetaxel plus nintedanib in a patient with lung adenocarcinoma and pulmonary fibrosis: A case report and literature review

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma

The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

Comparison of hook-wire and medical glue for CT-guided preoperative localization of pulmonary nodules

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations

Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health

Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study

Reduction of inter-observer variability using MRI and CT fusion in delineating of primary tumor for radiotherapy in lung cancer with atelectasis

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma

Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report